Rheumatoid Arthritis Increases Mortality Risk in Staphylococcus aureus Infections
Prospective cohort study examines clinical characteristics and outcomes of S aureus bacteremia in patients with rheumatoid arthritis.
Infection
Bone Metabolism Risks Associated With Tenofovir for Hepatitis B Infection
Long-term tenofovir treatment for hepatitis B infection is linked with abnormal phosphorus metabolism in a recent study.
Infliximab Discontinuation and Postoperative Infection Risk
Study examined patients who received infliximab for rheumatologic conditions and the incidence of postoperative infections.
Etanercept for Rheumatoid Arthritis Has Lower Infection Risk
The TNF inhibitor shows lower risk for infections and tuberculosis, according to a recent study.
End-Stage Renal Disease Risk Higher in SLE Patients Hospitalized for Infections
End-stage renal disease is 5-fold more likely to develop in patients with 3 or more infection-related hospitalizations versus none.
Switching From Rituximab to Other Biologic Does Not Alter Infection Risk in RA
A review and analysis of registry data from patients with RA indicates that changing from rituximab to another class of biologic agent does not alter the subsequent risk of infection.
Does bDMARD Exposure Change Mortality Risk in Septic RA Patients?
In the first study simultaneously evaluating sepsis and sepsis-related mortality in RA patients with serious infection, researchers found that any bDMARD exposure significantly lowered mortality rates.
Biologic Agents Associated with High Risk of HBV Flares in Psoriasis and Rheumatoid Arthritis
The use of biologic agents in treatment of patients rheumatoid arthritis or psoriasis is associated with a significant risk of heptatis B flares.
- Loading...
Loading...
Next post in Rheumatoid Arthritis
Loading... 
Loading...